BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Cucchetti A, Piscaglia F, Cescon M, Ercolani G, Pinna AD. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol 2013; 19(26): 4106-4118 [PMID: 23864773 DOI: 10.3748/wjg.v19.i26.4106]
URL: https://www.wjgnet.com/1007-9327/full/v19/i26/4106.htm
Number Citing Articles
1
Karen T. Brown, Anne M. Covey. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set2017; : 525 doi: 10.1016/B978-0-323-34062-5.00030-3
2
Masatoshi SHOJI, Hiroyuki TAKAMURA, Hironori HAYASHI, Shin-ichi NAKANUMA, Hirohisa KITAGAWA, Tetsuo OHTA. A Case of Recurrent Intraphepatic Cholangicarcinoma with Sarcomatous Change after Repeated Local TherapiesNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 2014; 75(7): 2001 doi: 10.3919/jjsa.75.2001
3
Takeshi Terashima, Yoichi Higashibeppu, Tatsuya Yamashita, Yukinori Sakata, Mie Azuma, Hiroaki Munakata, Mika Ishii, Shuichi Kaneko. Comparative analysis of medical costs after hepatectomy versus radiofrequency ablation in patients with hepatocellular carcinoma in real‐world clinical practiceHepatology Research 2022; 52(5): 471 doi: 10.1111/hepr.13756
4
A Cucchetti, V Mazzaferro, A D Pinna, C Sposito, R Golfieri, C Serra, C Spreafico, F Piscaglia, A Cappelli, M Bongini, M Cucchi, M Cescon. Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinomaBritish Journal of Surgery 2017; 104(12): 1704 doi: 10.1002/bjs.10613
5
Marc Bourlière, Stanislas Pol. AbstractsLiver International 2019; 39(12): 2420 doi: 10.1111/liv.14255
6
C. R. Wong, B. Njei, M. H. Nguyen, A. Nguyen, J. K. Lim. Survival after treatment with curative intent for hepatocellular carcinoma among patients with vs without non‐alcoholic fatty liver diseaseAlimentary Pharmacology & Therapeutics 2017; 46(11-12): 1061 doi: 10.1111/apt.14342
7
Stefania Brozzetti, Simone Bini, Chiara D’Alterio, Chiara De Lucia, Leonardo Luca Chiarella, Katia Fazzi, Michele Di Martino. Liver Disease and Surgery [Working Title]2019;  doi: 10.5772/intechopen.86638
8
Lisa P Waller, Vrushak Deshpande, Nikolaos Pyrsopoulos. Hepatocellular carcinoma: A comprehensive reviewWorld Journal of Hepatology 2015; 7(26): 2648-2663 doi: 10.4254/wjh.v7.i26.2648
9
Mohamed Mourad, Jean-Yves Mabrut, Madiha Chellakhi, Mickaël Lesurtel, Célia Prevost, Christian Ducerf, Agnès Rode, Philippe Merle, Françoise Mornex, Kayvan Mohkam. Neoadjuvant Conformal Radiotherapy Before Liver Transplantation for Hepatocellular Carcinoma: A Propensity Score Matched Analysis of Postoperative Morbidity and Oncological ResultsFuture Oncology 2019; 15(21): 2517 doi: 10.2217/fon-2019-0127
10
Gonzalo Sapisochin, Elena Fernandez de Sevilla, Juan Echeverri, Ramón Charco. Management of “very early” hepatocellular carcinoma on cirrhotic patientsWorld Journal of Hepatology 2014; 6(11): 766-775 doi: 10.4254/wjh.v6.i11.766
11
Samantha M. Ruff, Adam Khader, Charles Conte, Alan Kadison, James Sullivan, John Wang, Raza Zaidi, Gary B. Deutsch. Improved outcomes with surgery compared to radiofrequency ablation in the treatment of resectable hepatocellular carcinomaEuropean Journal of Gastroenterology & Hepatology 2019; 31(11): 1397 doi: 10.1097/MEG.0000000000001416
12
Zhao-Shan Niu, Xiao-Jun Niu, Mei Wang. Management of hepatocellular carcinoma: Predictive value of immunohistochemical markers for postoperative survivalWorld Journal of Hepatology 2015; 7(1): 7-27 doi: 10.4254/wjh.v7.i1.7
13
Konrad Mohnike, Ingo G. Steffen, Max Seidensticker, Peter Hass, Robert Damm, Nils Peters, Ricarda Seidensticker, Kerstin Schütte, Jörg Arend, Jan Bornschein, Tina Streitparth, Christian Wybranski, Gero Wieners, Patrick Stübs, Peter Malfertheiner, Maciej Pech, Jens Ricke. Radioablation by Image-Guided (HDR) Brachytherapy and Transarterial Chemoembolization in Hepatocellular Carcinoma: A Randomized Phase II TrialCardioVascular and Interventional Radiology 2019; 42(2): 239 doi: 10.1007/s00270-018-2127-5
14
Yasunobu Matsuda, Toshifumi Wakai, Yuki Hirose, Mami Osawa, Shun Fujimaki, Masayuki Kubota. p27 Is a Critical Prognostic Biomarker in Non-Alcoholic Steatohepatitis-Related Hepatocellular CarcinomaInternational Journal of Molecular Sciences 2013; 14(12): 23499 doi: 10.3390/ijms141223499
15
Shengyong Yin, Xudong Miao, Xueming Zhang, Xinhua Chen, Hao Wen. Environmental temperature affects physiology and survival of nanosecond pulsed electric field‐treated cellsJournal of Cellular Physiology 2018; 233(2): 1179 doi: 10.1002/jcp.25984
16
Masashi Mizumoto, Yoshiko Oshiro, Toshiyuki Okumura, Kuniaki Fukuda, Nobuyoshi Fukumitsu, Masato Abei, Hitoshi Ishikawa, Kayoko Ohnishi, Haruko Numajiri, Koji Tsuboi, Hideyuki Sakurai. Association between pretreatment retention rate of indocyanine green 15 min after administration and life prognosis in patients with HCC treated by proton beam therapyRadiotherapy and Oncology 2014; 113(1): 54 doi: 10.1016/j.radonc.2014.08.015
17
Arnaud Hocquelet, Pierre Balageas, Christophe Laurent, Jean-Frédéric Blanc, Nora Frulio, Cécile Salut, Christophe Cassinotto, Jean Saric, Laurent Possenti, Pierre-Henri Bernard, Michel Montaudon, Hervé Trillaud. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: A study of 281 Western patientsInternational Journal of Hyperthermia 2015; 31(7): 749 doi: 10.3109/02656736.2015.1068382
18
N. Scher, G. Janoray, F.-G. Riet, A.-G. Le Bayon, K. Debbi, S. Lévy, P. Louisot, P. Garaud, E. Chajon, I. Barillot, É. Salamé, R. de Crevoisier, S. Chapet, G. Calais. Radiothérapie en conditions stéréotaxiques du carcinome hépatocellulaire : résultats d’une étude rétrospective multicentriqueCancer/Radiothérapie 2019; 23(2): 104 doi: 10.1016/j.canrad.2018.07.138
19
Kevin Ka Wan Chu, Tan To Cheung. Update in management of hepatocellular carcinoma in Eastern populationWorld Journal of Hepatology 2015; 7(11): 1562-1571 doi: 10.4254/wjh.v7.i11.1562
20
Alessandro Granito, Luigi Bolondi. Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosisThe Lancet Oncology 2017; 18(2): e101 doi: 10.1016/S1470-2045(16)30569-1
21
T. Hofmockel, V. Plodeck, M. Laniado, R.-T. Hoffmann. Thermoablative Therapie des hepatozellulären KarzinomsDer Radiologe 2014; 54(7): 679 doi: 10.1007/s00117-014-2654-2
22
Xiangzhong Huang, Xinjian Xu, Hongtao Du, Qiulian Sun, Minyu Wu. Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumorsInternational Journal of Hyperthermia 2024; 41(1) doi: 10.1080/02656736.2023.2300347
23
Akiko Ishigami, Shogo Inaka, Yuko Ishida, Mizuho Nosaka, Yumi Kuninaka, Hiroki Yamamoto, Emi Shimada, Akihiko Kimura, Fukumi Furukawa, Toshikazu Kondo. A case of hemoperitoneum after percutaneous radiofrequency ablation in a patient with hepatocellular carcinomaForensic Science, Medicine and Pathology 2023; 20(1): 189 doi: 10.1007/s12024-023-00601-w
24
Gaeun Kim, Soon Koo Baik. Overview and recent trends of systematic reviews and meta-analyses in hepatologyClinical and Molecular Hepatology 2014; 20(2): 137 doi: 10.3350/cmh.2014.20.2.137
25
CHAOHUI ZUO, MAN XIA, QUNFENG WU, HAIZHEN ZHU, JINGSHI LIU, CHEN LIU. Role of antiviral therapy in reducing recurrence and improving survival in hepatitis B virus-associated hepatocellular carcinoma following curative resection (Review)Oncology Letters 2015; 9(2): 527 doi: 10.3892/ol.2014.2727
26
Wan Yee Lau, Stephanie Hiu Yan Lau. The current role of radiofrequency ablation in the treatment of hepatocellular carcinomaHepatobiliary & Pancreatic Diseases International 2017; 16(2): 122 doi: 10.1016/S1499-3872(16)60182-0
27
Dong-Sheng Sun, Cang-Hai Guan, Wei-Na Wang, Zeng-Tao Hu, Yu-Qiao Zhao, Xing-Ming Jiang. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axisMicrovascular Research 2021; 134: 104120 doi: 10.1016/j.mvr.2020.104120
28
Kazuki Murai, Akira Yamamoto, Ken Kageyama, Mariko Nakano, Atsushi Jogo, Yukio Miki. A case of recurrent laryngeal nerve paralysis caused by radiofrequency ablation for mediastinal recurrence of lung cancerRadiology Case Reports 2024; 19(4): 1397 doi: 10.1016/j.radcr.2023.12.059
29
Hla‐Hla Thein, Wanrudee Isaranuwatchai, Yao Qiao, Kenny Wong, Gonzalo Sapisochin, Kelvin K. W. Chan, Eric M. Yoshida, Craig C. Earle. Cost‐effectiveness analysis of potentially curative and combination treatments for hepatocellular carcinoma with person‐level data in a Canadian settingCancer Medicine 2017; 6(9): 2017 doi: 10.1002/cam4.1119
30
Antonio Facciorusso, Michele Barone. Hepatocellular Carcinoma2016; : 453 doi: 10.1007/978-3-319-34214-6_30
31
Moon Haeng Hur, Jeong-Hoon Lee, Ju Yeon Kim, Ji Hoon Hong, Min Kyung Park, Hee Jin Cho, Na Ryung Choi, Jihye Kim, Minseok Albert Kim, Joon Yeul Nam, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Dong Ho Lee, Jeong Min Lee, Suk Kyun Hong, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Jung-Hwan Yoon. Comparison of Overall Survival between Surgical Resection and Radiofrequency Ablation for Hepatitis B-Related Hepatocellular CarcinomaCancers 2021; 13(23): 6009 doi: 10.3390/cancers13236009
32
Jeffrey S. Wicks, Benjamin S. Dale, Luis Ruffolo, Ludia J. Pack, Richard Dunne, Marie A. Laryea, Roberto Hernandez-Alejandro, Ashwani Kumar Sharma. Comparable and Complimentary Modalities for Treatment of Small-Sized HCC: Surgical Resection, Radiofrequency Ablation, and Microwave AblationJournal of Clinical Medicine 2023; 12(15): 5006 doi: 10.3390/jcm12155006
33
Darren W. Chua, Ye-Xin Koh, Nicholas L. Syn, Tan Yu Chuan, Teo Jin Yao, Ser-Yee Lee, Brian K. P. Goh, Peng-Chung Cheow, Alexander Y. Chung, Chung-Yip Chan. Repeat hepatectomy versus radiofrequency ablation in management of recurrent hepatocellular carcinoma: an average treatment effect analysisAnnals of Surgical Oncology 2021; 28(12): 7731 doi: 10.1245/s10434-021-09948-2
34
Gianni Testino, Silvia Leone, Paolo Borro. Alcohol and hepatocellular carcinoma: A review and a point of viewWorld Journal of Gastroenterology 2014; 20(43): 15943-15954 doi: 10.3748/wjg.v20.i43.15943
35
Shoujin Cao, Yinghua Zou, Tianshi Lyu, Zeyang Fan, Haitao Guan, Li Song, Xiaoqiang Tong, Jian Wang. Long-term outcomes of combined transarterial chemoembolization and radiofrequency ablation versus RFA monotherapy for single hepatocellular carcinoma ≤3 cm: emphasis on local tumor progressionInternational Journal of Hyperthermia 2022; 39(1): 1 doi: 10.1080/02656736.2021.1998660
36
Gaya Spolverato, Alessandro Vitale, Aslam Ejaz, Yuhree Kim, Shishir K. Maithel, David P. Cosgrove, Timothy M. Pawlik. The Relative Net Health Benefit of Liver Resection, Ablation, and Transplantation for Early Hepatocellular CarcinomaWorld Journal of Surgery 2015; 39(6): 1474 doi: 10.1007/s00268-015-2987-7
37
Simon Chun Ho Yu, Joyce Wai Yi Hui, Charing Ching Ning Chong, Cheuk Man Chu, Sunny Cheung, John Wong, Kit Fai Lee. Transarterial Ethanol Ablation for Small Hepatocellular Carcinoma (≤ 3 cm): A Comparative Study Versus Radiofrequency AblationCardioVascular and Interventional Radiology 2020; 43(5): 732 doi: 10.1007/s00270-020-02426-4
38
Kevin N. Shah, Bryan M. Clary. Endoscopic and Percutaneous Approaches to the Treatment of Biliary Tract and Primary Liver TumorsSurgical Oncology Clinics of North America 2014; 23(2): 207 doi: 10.1016/j.soc.2013.10.003
39
Hao Chen, Chun-Hui Yuan, Yi-Fei Yang, Chang-Qing Yin, Qing Guan, Fu-Bing Wang, Jian-Cheng Tu. Subtractive Cell-SELEX Selection of DNA Aptamers Binding Specifically and Selectively to Hepatocellular Carcinoma Cells with High Metastatic PotentialBioMed Research International 2016; 2016: 1 doi: 10.1155/2016/5735869
40
Davide Ippolito, Anna Pecorelli, Giulia Querques, Silvia Girolama Drago, Cesare Maino, Cammillo Talei Franzesi, Adam Hatzidakis, Sandro Sironi. Dynamic Computed Tomography Perfusion Imaging: Complementary Diagnostic Tool in Hepatocellular Carcinoma Assessment From Diagnosis to Treatment Follow-upAcademic Radiology 2019; 26(12): 1675 doi: 10.1016/j.acra.2019.02.010
41
Gelareh Sadigh, Nadine Abi-Jaoudeh. Surgery Versus Ablation for Small Hepatocellular Carcinoma Treatment and Role of Personalized MedicineJournal of the American College of Radiology 2022; 19(11): 1224 doi: 10.1016/j.jacr.2022.09.023
42
Alessandro Cucchetti, Fabio Piscaglia, Matteo Cescon, Carla Serra, Antonio Colecchia, Lorenzo Maroni, Laura Venerandi, Giorgio Ercolani, Antonio Daniele Pinna. An explorative data-analysis to support the choice between hepatic resection and radiofrequency ablation in the treatment of hepatocellular carcinomaDigestive and Liver Disease 2014; 46(3): 257 doi: 10.1016/j.dld.2013.10.015
43
Antonio Facciorusso, Gaetano Serviddio, Nicola Muscatiello. Local ablative treatments for hepatocellular carcinoma: An updated reviewWorld Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(4): 477-489 doi: 10.4292/wjgpt.v7.i4.477
44
Hao-Wen Sim, Jennifer Knox, Laura A. Dawson. An Update on Randomized Clinical Trials in Hepatocellular CarcinomaSurgical Oncology Clinics of North America 2017; 26(4): 647 doi: 10.1016/j.soc.2017.05.006
45
Jia-yan Ni, Lin-feng Xu, Hong-liang Sun, Jing-xing Zhou, Yao-ting Chen, Jiang-hong Luo. Percutaneous ablation therapy versus surgical resection in the treatment for early-stage hepatocellular carcinoma: a meta-analysis of 21,494 patientsJournal of Cancer Research and Clinical Oncology 2013; 139(12): 2021 doi: 10.1007/s00432-013-1530-1
46
Danyang Chao, Lijun Pang, Ying Shi, Wenjing Wang, Kai Liu. AZD3759 induces apoptosis in hepatoma cells by activating a p53-SMAD4 positive feedback loopBiochemical and Biophysical Research Communications 2019; 509(2): 535 doi: 10.1016/j.bbrc.2018.12.102
47
Alessandro Cucchetti, Omar Elshaarawy, Guohong Han, Charing C. N. Chong, Carla Serra, Joanne Marie O’Rourke, Richard Crew, Cristina Felicani, Giorgio Ercolani, Tahir Shah, Arndt Vogel, Paul B. S. Lai, Philip J. Johnson. ‘Potentially curative therapies’ for hepatocellular carcinoma: how many patients can actually be cured?British Journal of Cancer 2023; 128(9): 1665 doi: 10.1038/s41416-023-02188-z
48
Resmi A. Charalel, Alvin I. Mushlin, Xinyan Zheng, Jialin Mao, Ruth C. Carlos, Robert S. Brown, Brett E. Fortune, Adam D. Talenfeld, David C. Madoff, Said Ibrahim, Matthew S. Johnson, Art Sedrakyan. Beyond Survival: Adverse Events and Care Delivery Outcomes after Early Liver Cancer Treatment in a Nationally Representative CohortJournal of Vascular and Interventional Radiology 2023; 34(11): 1997 doi: 10.1016/j.jvir.2023.07.010
49
Abigail Mills, David Thayer, Christopher Noda, Amber Salter, Yu Tao, Minzhi Xing, Robert Martin, Raja Ramaswamy, Olaguoke Akinwande. Thermal Ablation Versus Surgical Resection for Localized Hepatocellular Carcinoma: A Population Study Using the SEER DatabaseFuture Oncology 2018; 14(7): 631 doi: 10.2217/fon-2017-0447
50
Yandong Wang, Xiang Jing, Jianmin Ding. Clinical value of dynamic 3-dimensional contrast-enhanced ultrasound imaging for the assessment of hepatocellular carcinoma ablationClinical Imaging 2016; 40(3): 402 doi: 10.1016/j.clinimag.2015.11.022
51
Qinghua Xu, Seijin Kobayashi, Xun Ye, Xia Meng. Comparison of Hepatic Resection and Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Meta-Analysis of 16,103 PatientsScientific Reports 2014; 4(1) doi: 10.1038/srep07252
52
Dirk Graf, Daniel Vallböhmer, Wolfram Trudo Knoefel, Patric Kröpil, Gerald Antoch, Abdurrahaman Sagir, Dieter Häussinger. Multimodal treatment of hepatocellular carcinomaEuropean Journal of Internal Medicine 2014; 25(5): 430 doi: 10.1016/j.ejim.2014.03.001
53
Federica Invernizzi, Massimo Colombo. Pathway of Care of Hepatocellular Carcinoma in 2017Hepatic Oncology 2016; 3(4): 217 doi: 10.2217/hep-2017-0004
54
Jennifer J. Knox, Sean P. Cleary, Laura A. Dawson. Localized and Systemic Approaches to Treating Hepatocellular CarcinomaJournal of Clinical Oncology 2015; 33(16): 1835 doi: 10.1200/JCO.2014.60.1153
55
Jiping Wang, Yunju Im, Rong Wang, Shuangge Ma. Partial Hepatectomy and Ablation for Survival of Early-Stage Hepatocellular Carcinoma Patients: A Bayesian Emulation AnalysisLife 2024; 14(6): 661 doi: 10.3390/life14060661
56
Chih-Hao Lin, Cheng-Maw Ho, Chih-Horng Wu, Po-Chin Liang, Yao-Ming Wu, Rey-Heng Hu, Po-Huang Lee, Ming-Chih Ho. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosisSurgical Endoscopy 2020; 34(12): 5566 doi: 10.1007/s00464-019-07357-x
57
Luca Quagliata, Manuel Schlageter, Cristina Quintavalle, Luigi Tornillo, Luigi Terracciano. Identification of New Players in Hepatocarcinogenesis: Limits and Opportunities of Using Tissue Microarray (TMA)Microarrays 2014; 3(2): 91 doi: 10.3390/microarrays3020091
58
Pankaj Gupta, Naveen Kalra, Shyamkumar N. Keshava, Sreedhara B. Chaluvashetty, Amar Mukund, Shuvro H. Roy-Choudhury, Sanjay Saran Baijal, Anubhav Khandelwal, Venkatesh Hosur Ananthashayana, Sathya Narayanan R., Suyash Kulkarni, Nitin Sudhakar Shetty, Arun Gupta, Sanjay Gupta. Indian Society of Vascular and Interventional Radiology Expert Consensus Statements for Ablation in Hepatocellular Carcinoma: Part IJournal of Clinical Interventional Radiology ISVIR 2020; 4(02): 098 doi: 10.1055/s-0040-1715774
59
Subrat K. Acharya. Treatment for Hepatocellular Carcinoma in South AsiaJournal of Clinical and Experimental Hepatology 2021; 11(6): 641 doi: 10.1016/j.jceh.2021.09.018
60
Zhang Zhong-yi, Yang Wei, Yan Kun, Dai Ying, Wu Wei, Lee Jung-chieh, Chen Min-hua. Needle track seeding after percutaneous radiofrequency ablation of hepatocellular carcinoma: 14-year experience at a single centreInternational Journal of Hyperthermia 2017; 33(4): 454 doi: 10.1080/02656736.2017.1278630
61
Akiyoshi Kinoshita, Kazuhiko Koike, Hirokazu Nishino. Clinical features and prognosis of elderly patients with hepatocellular carcinoma not indicated for surgical resectionGeriatrics & Gerontology International 2017; 17(2): 189 doi: 10.1111/ggi.12747
62
Matteo Canale, Francesco Giuseppe Foschi, Pietro Andreone, Giorgio Ercolani, Giorgia Marisi, Fabio Conti, Ranka Vukotic, Valeria Guarneri, Valentina Burgio, Francesca Ratti, Luca Aldrighetti, Francesco De Cobelli, Stefano Cascinu, Paola Ulivi, Andrea Casadei-Gardini. Role of circulating microRNAs to predict hepatocellular carcinoma recurrence in patients treated with radiofrequency ablation or surgeryHPB 2022; 24(2): 244 doi: 10.1016/j.hpb.2021.06.421
63
Hwaseong Ryu, Tae Un Kim, Jun Woo Lee, Ung Bae Jeon, Jin Hyeok Kim, Joo Yeon Jang, Ki Tae Yoon, Young Mi Hong. Factors associated with increased risk of peritoneal seeding after radiofrequency ablation for hepatocellular carcinomaAbdominal Radiology 2023; 48(10): 3243 doi: 10.1007/s00261-023-03987-x